Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO) with GMP facilities in Belgium, Spain, the Netherlands and Sweden, has signed a definitive agreement to acquire Catalent’s state-of-the-art facility in Somerset, NJ.   This acquisition will significantly enhance Ardena’s capabilities in downstream late-stage and small-scale commercial manufacturing of oral drug products, supporting its strategy to become a leading global CDMO offering integrated solu...